UMD Catalyst Grant: Maaike Oosterveer
Liver disease, in particular hepatic tumorigenesis, represent a serious long-term complication in adult patients suffering from Glycogen Storage Disease type 1a (GSD Ia). Current dietary management primarily aims to prevent life-threatening hypoglycemia, and does generally not prevent liver disease. It is therefore critical to explore novel therapeutic strategies.
In this collaborative and preclinical research project Dr. Maaike Oosterveer (UMCG Laboratory of Pediatrics) and Prof. Dr. Riekelt Houtkooper (AMC Laboratory of Genetic Metabolic Diseases) will investigate the impact of dietary supplementation on development of liver disease in GSD Ia.
https://www.unitedformetabolicdiseases.nl/english/home.html
Last modified: | 21 September 2020 11.08 a.m. |
More news
-
16 April 2024
UG signs Barcelona Declaration on Open Research Information
In a significant stride toward advancing responsible research assessment and open science, the University of Groningen has officially signed the Barcelona Declaration on Open Research Information.
-
02 April 2024
Flying on wood dust
Every two weeks, UG Makers puts the spotlight on a researcher who has created something tangible, ranging from homemade measuring equipment for academic research to small or larger products that can change our daily lives. That is how UG...
-
18 March 2024
VentureLab North helps researchers to develop succesful startups
It has happened to many researchers. While working, you suddenly ask yourself: would this not be incredibly useful for people outside of my own research discipline? There are many ways to share the results of your research. For example, think of a...